These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 32301520

  • 1. Translocation domain of botulinum neurotoxin A subtype 2 potently induces entry into neuronal cells.
    Kohda T, Tsukamoto K, Torii Y, Kozaki S, Mukamoto M.
    Microbiol Immunol; 2020 Jul; 64(7):502-511. PubMed ID: 32301520
    [Abstract] [Full Text] [Related]

  • 2. The Light Chain Defines the Duration of Action of Botulinum Toxin Serotype A Subtypes.
    Pellett S, Bradshaw M, Tepp WH, Pier CL, Whitemarsh RCM, Chen C, Barbieri JT, Johnson EA.
    mBio; 2018 Mar 27; 9(2):. PubMed ID: 29588398
    [Abstract] [Full Text] [Related]

  • 3. High resolution crystal structures of Clostridium botulinum neurotoxin A3 and A4 binding domains.
    Davies JR, Rees J, Liu SM, Acharya KR.
    J Struct Biol; 2018 May 27; 202(2):113-117. PubMed ID: 29288126
    [Abstract] [Full Text] [Related]

  • 4. Isolation and Characterization of the Novel Botulinum Neurotoxin A Subtype 6.
    Moritz MS, Tepp WH, Bradshaw M, Johnson EA, Pellett S.
    mSphere; 2018 Oct 24; 3(5):. PubMed ID: 30355669
    [Abstract] [Full Text] [Related]

  • 5. Entry of Botulinum Neurotoxin Subtypes A1 and A2 into Neurons.
    Kroken AR, Blum FC, Zuverink M, Barbieri JT.
    Infect Immun; 2017 Jan 24; 85(1):. PubMed ID: 27795365
    [Abstract] [Full Text] [Related]

  • 6. Holotoxin Activity of Botulinum Neurotoxin Subtype A4 Originating from a Nontoxigenic Clostridium botulinum Expression System.
    Bradshaw M, Tepp WH, Whitemarsh RC, Pellett S, Johnson EA.
    Appl Environ Microbiol; 2014 Dec 24; 80(23):7415-22. PubMed ID: 25239905
    [Abstract] [Full Text] [Related]

  • 7. Enhancing toxin-based vaccines against botulism.
    Przedpelski A, Tepp WH, Zuverink M, Johnson EA, Pellet S, Barbieri JT.
    Vaccine; 2018 Feb 01; 36(6):827-832. PubMed ID: 29307477
    [Abstract] [Full Text] [Related]

  • 8. Isolation and functional characterization of the novel Clostridium botulinum neurotoxin A8 subtype.
    Kull S, Schulz KM, Weisemann J, Kirchner S, Schreiber T, Bollenbach A, Dabrowski PW, Nitsche A, Kalb SR, Dorner MB, Barr JR, Rummel A, Dorner BG.
    PLoS One; 2015 Feb 01; 10(2):e0116381. PubMed ID: 25658638
    [Abstract] [Full Text] [Related]

  • 9. Novel chimeras of botulinum neurotoxins A and E unveil contributions from the binding, translocation, and protease domains to their functional characteristics.
    Wang J, Meng J, Lawrence GW, Zurawski TH, Sasse A, Bodeker MO, Gilmore MA, Fernández-Salas E, Francis J, Steward LE, Aoki KR, Dolly JO.
    J Biol Chem; 2008 Jun 20; 283(25):16993-7002. PubMed ID: 18400760
    [Abstract] [Full Text] [Related]

  • 10. Catalytic properties of botulinum neurotoxin subtypes A3 and A4.
    Henkel JS, Jacobson M, Tepp W, Pier C, Johnson EA, Barbieri JT.
    Biochemistry; 2009 Mar 24; 48(11):2522-8. PubMed ID: 19256469
    [Abstract] [Full Text] [Related]

  • 11. High Yield Preparation of Functionally Active Catalytic-Translocation Domain Module of Botulinum Neurotoxin Type A That Exhibits Uniquely Different Enzyme Kinetics.
    Dhaliwal HK, Thiruvanakarasu N, Kumar R, Patel K, Ambrin G, Cai S, Singh BR.
    Protein J; 2017 Dec 24; 36(6):489-501. PubMed ID: 29030733
    [Abstract] [Full Text] [Related]

  • 12. Comparison of the catalytic properties of the botulinum neurotoxin subtypes A1 and A5.
    Wang D, Krilich J, Pellett S, Baudys J, Tepp WH, Barr JR, Johnson EA, Kalb SR.
    Biochim Biophys Acta; 2013 Dec 24; 1834(12):2722-8. PubMed ID: 24096023
    [Abstract] [Full Text] [Related]

  • 13. The C-terminal heavy-chain domain of botulinum neurotoxin a is not the only site that binds neurons, as the N-terminal heavy-chain domain also plays a very active role in toxin-cell binding and interactions.
    Ayyar BV, Aoki KR, Atassi MZ.
    Infect Immun; 2015 Apr 24; 83(4):1465-76. PubMed ID: 25624352
    [Abstract] [Full Text] [Related]

  • 14. Characterization of the antibody response to the receptor binding domain of botulinum neurotoxin serotypes A and E.
    Baldwin MR, Tepp WH, Pier CL, Bradshaw M, Ho M, Wilson BA, Fritz RB, Johnson EA, Barbieri JT.
    Infect Immun; 2005 Oct 24; 73(10):6998-7005. PubMed ID: 16177380
    [Abstract] [Full Text] [Related]

  • 15. Exchanging the minimal cell binding fragments of tetanus neurotoxin in botulinum neurotoxin A and B impacts their toxicity at the neuromuscular junction and central neurons.
    Höltje M, Schulze S, Strotmeier J, Mahrhold S, Richter K, Binz T, Bigalke H, Ahnert-Hilger G, Rummel A.
    Toxicon; 2013 Dec 01; 75():108-21. PubMed ID: 23817019
    [Abstract] [Full Text] [Related]

  • 16. Substrate cleavage and duration of action of botulinum neurotoxin type FA ("H, HA").
    Pellett S, Tepp WH, Lin G, Johnson EA.
    Toxicon; 2018 Jun 01; 147():38-46. PubMed ID: 29273248
    [Abstract] [Full Text] [Related]

  • 17. Characterization of the functional activity of botulinum neurotoxin subtype B6.
    Kohda T, Nakamura K, Hosomi K, Torii Y, Kozaki S, Mukamoto M.
    Microbiol Immunol; 2017 Nov 01; 61(11):482-489. PubMed ID: 28898517
    [Abstract] [Full Text] [Related]

  • 18. Characterization of botulinum neurotoxin A subtypes 1 through 5 by investigation of activities in mice, in neuronal cell cultures, and in vitro.
    Whitemarsh RC, Tepp WH, Bradshaw M, Lin G, Pier CL, Scherf JM, Johnson EA, Pellett S.
    Infect Immun; 2013 Oct 01; 81(10):3894-902. PubMed ID: 23918782
    [Abstract] [Full Text] [Related]

  • 19. A viral-fusion-peptide-like molecular switch drives membrane insertion of botulinum neurotoxin A1.
    Lam KH, Guo Z, Krez N, Matsui T, Perry K, Weisemann J, Rummel A, Bowen ME, Jin R.
    Nat Commun; 2018 Dec 18; 9(1):5367. PubMed ID: 30560862
    [Abstract] [Full Text] [Related]

  • 20. Potency Evaluations of Recombinant Botulinum Neurotoxin A1 Mutants Designed to Reduce Toxicity.
    Viravathana P, Tepp WH, Bradshaw M, Przedpelski A, Barbieri JT, Pellett S.
    Int J Mol Sci; 2024 Aug 17; 25(16):. PubMed ID: 39201641
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.